Global Personalized Medicine Market Research Report 2021-2025
Personalized medicine is a new mantra evolving in health care. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Personalized Medicine Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
In this report, the global Personalized Medicine market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Personalized Medicine basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Illumina, Inc.
GE Healthcare
Danaher Corporation (Cepheid, Inc.)
Abbott
QIAGEN
Exact Sciences Corporation
ASURAGEN, INC.
Biogen
Dako A/S
Exagen Inc.
Precision Biologics
Celera Diagnostics LLC
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
General Type
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Personalized Medicine for each application, including-
Medical
In this report, the global Personalized Medicine market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Personalized Medicine basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Illumina, Inc.
GE Healthcare
Danaher Corporation (Cepheid, Inc.)
Abbott
QIAGEN
Exact Sciences Corporation
ASURAGEN, INC.
Biogen
Dako A/S
Exagen Inc.
Precision Biologics
Celera Diagnostics LLC
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
General Type
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Personalized Medicine for each application, including-
Medical
PART I PERSONALIZED MEDICINE INDUSTRY OVERVIEW
CHAPTER ONE PERSONALIZED MEDICINE INDUSTRY OVERVIEW
1.1 Personalized Medicine Definition
1.2 Personalized Medicine Classification Analysis
1.2.1 Personalized Medicine Main Classification Analysis
1.2.2 Personalized Medicine Main Classification Share Analysis
1.3 Personalized Medicine Application Analysis
1.3.1 Personalized Medicine Main Application Analysis
1.3.2 Personalized Medicine Main Application Share Analysis
1.4 Personalized Medicine Industry Chain Structure Analysis
1.5 Personalized Medicine Industry Development Overview
1.5.1 Personalized Medicine Product History Development Overview
1.5.1 Personalized Medicine Product Market Development Overview
1.6 Personalized Medicine Global Market Comparison Analysis
1.6.1 Personalized Medicine Global Import Market Analysis
1.6.2 Personalized Medicine Global Export Market Analysis
1.6.3 Personalized Medicine Global Main Region Market Analysis
1.6.4 Personalized Medicine Global Market Comparison Analysis
1.6.5 Personalized Medicine Global Market Development Trend Analysis
CHAPTER TWO PERSONALIZED MEDICINE UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Personalized Medicine Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA PERSONALIZED MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA PERSONALIZED MEDICINE MARKET ANALYSIS
3.1 Asia Personalized Medicine Product Development History
3.2 Asia Personalized Medicine Competitive Landscape Analysis
3.3 Asia Personalized Medicine Market Development Trend
CHAPTER FOUR 2016-2021 ASIA PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Personalized Medicine Production Overview
4.2 2016-2021 Personalized Medicine Production Market Share Analysis
4.3 2016-2021 Personalized Medicine Demand Overview
4.4 2016-2021 Personalized Medicine Supply Demand and Shortage
4.5 2016-2021 Personalized Medicine Import Export Consumption
4.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Personalized Medicine Production Overview
6.2 2021-2025 Personalized Medicine Production Market Share Analysis
6.3 2021-2025 Personalized Medicine Demand Overview
6.4 2021-2025 Personalized Medicine Supply Demand and Shortage
6.5 2021-2025 Personalized Medicine Import Export Consumption
6.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART III NORTH AMERICAN PERSONALIZED MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN PERSONALIZED MEDICINE MARKET ANALYSIS
7.1 North American Personalized Medicine Product Development History
7.2 North American Personalized Medicine Competitive Landscape Analysis
7.3 North American Personalized Medicine Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Personalized Medicine Production Overview
8.2 2016-2021 Personalized Medicine Production Market Share Analysis
8.3 2016-2021 Personalized Medicine Demand Overview
8.4 2016-2021 Personalized Medicine Supply Demand and Shortage
8.5 2016-2021 Personalized Medicine Import Export Consumption
8.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Personalized Medicine Production Overview
10.2 2021-2025 Personalized Medicine Production Market Share Analysis
10.3 2021-2025 Personalized Medicine Demand Overview
10.4 2021-2025 Personalized Medicine Supply Demand and Shortage
10.5 2021-2025 Personalized Medicine Import Export Consumption
10.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART IV EUROPE PERSONALIZED MEDICINE INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE PERSONALIZED MEDICINE MARKET ANALYSIS
11.1 Europe Personalized Medicine Product Development History
11.2 Europe Personalized Medicine Competitive Landscape Analysis
11.3 Europe Personalized Medicine Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Personalized Medicine Production Overview
12.2 2016-2021 Personalized Medicine Production Market Share Analysis
12.3 2016-2021 Personalized Medicine Demand Overview
12.4 2016-2021 Personalized Medicine Supply Demand and Shortage
12.5 2016-2021 Personalized Medicine Import Export Consumption
12.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Personalized Medicine Production Overview
14.2 2021-2025 Personalized Medicine Production Market Share Analysis
14.3 2021-2025 Personalized Medicine Demand Overview
14.4 2021-2025 Personalized Medicine Supply Demand and Shortage
14.5 2021-2025 Personalized Medicine Import Export Consumption
14.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART V PERSONALIZED MEDICINE MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN PERSONALIZED MEDICINE MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Personalized Medicine Marketing Channels Status
15.2 Personalized Medicine Marketing Channels Characteristic
15.3 Personalized Medicine Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN PERSONALIZED MEDICINE NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Personalized Medicine Market Analysis
17.2 Personalized Medicine Project SWOT Analysis
17.3 Personalized Medicine New Project Investment Feasibility Analysis
PART VI GLOBAL PERSONALIZED MEDICINE INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Personalized Medicine Production Overview
18.2 2016-2021 Personalized Medicine Production Market Share Analysis
18.3 2016-2021 Personalized Medicine Demand Overview
18.4 2016-2021 Personalized Medicine Supply Demand and Shortage
18.5 2016-2021 Personalized Medicine Import Export Consumption
18.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Personalized Medicine Production Overview
19.2 2021-2025 Personalized Medicine Production Market Share Analysis
19.3 2021-2025 Personalized Medicine Demand Overview
19.4 2021-2025 Personalized Medicine Supply Demand and Shortage
19.5 2021-2025 Personalized Medicine Import Export Consumption
19.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL PERSONALIZED MEDICINE INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE PERSONALIZED MEDICINE INDUSTRY OVERVIEW
1.1 Personalized Medicine Definition
1.2 Personalized Medicine Classification Analysis
1.2.1 Personalized Medicine Main Classification Analysis
1.2.2 Personalized Medicine Main Classification Share Analysis
1.3 Personalized Medicine Application Analysis
1.3.1 Personalized Medicine Main Application Analysis
1.3.2 Personalized Medicine Main Application Share Analysis
1.4 Personalized Medicine Industry Chain Structure Analysis
1.5 Personalized Medicine Industry Development Overview
1.5.1 Personalized Medicine Product History Development Overview
1.5.1 Personalized Medicine Product Market Development Overview
1.6 Personalized Medicine Global Market Comparison Analysis
1.6.1 Personalized Medicine Global Import Market Analysis
1.6.2 Personalized Medicine Global Export Market Analysis
1.6.3 Personalized Medicine Global Main Region Market Analysis
1.6.4 Personalized Medicine Global Market Comparison Analysis
1.6.5 Personalized Medicine Global Market Development Trend Analysis
CHAPTER TWO PERSONALIZED MEDICINE UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Personalized Medicine Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA PERSONALIZED MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA PERSONALIZED MEDICINE MARKET ANALYSIS
3.1 Asia Personalized Medicine Product Development History
3.2 Asia Personalized Medicine Competitive Landscape Analysis
3.3 Asia Personalized Medicine Market Development Trend
CHAPTER FOUR 2016-2021 ASIA PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Personalized Medicine Production Overview
4.2 2016-2021 Personalized Medicine Production Market Share Analysis
4.3 2016-2021 Personalized Medicine Demand Overview
4.4 2016-2021 Personalized Medicine Supply Demand and Shortage
4.5 2016-2021 Personalized Medicine Import Export Consumption
4.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Personalized Medicine Production Overview
6.2 2021-2025 Personalized Medicine Production Market Share Analysis
6.3 2021-2025 Personalized Medicine Demand Overview
6.4 2021-2025 Personalized Medicine Supply Demand and Shortage
6.5 2021-2025 Personalized Medicine Import Export Consumption
6.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART III NORTH AMERICAN PERSONALIZED MEDICINE INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN PERSONALIZED MEDICINE MARKET ANALYSIS
7.1 North American Personalized Medicine Product Development History
7.2 North American Personalized Medicine Competitive Landscape Analysis
7.3 North American Personalized Medicine Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Personalized Medicine Production Overview
8.2 2016-2021 Personalized Medicine Production Market Share Analysis
8.3 2016-2021 Personalized Medicine Demand Overview
8.4 2016-2021 Personalized Medicine Supply Demand and Shortage
8.5 2016-2021 Personalized Medicine Import Export Consumption
8.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Personalized Medicine Production Overview
10.2 2021-2025 Personalized Medicine Production Market Share Analysis
10.3 2021-2025 Personalized Medicine Demand Overview
10.4 2021-2025 Personalized Medicine Supply Demand and Shortage
10.5 2021-2025 Personalized Medicine Import Export Consumption
10.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART IV EUROPE PERSONALIZED MEDICINE INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE PERSONALIZED MEDICINE MARKET ANALYSIS
11.1 Europe Personalized Medicine Product Development History
11.2 Europe Personalized Medicine Competitive Landscape Analysis
11.3 Europe Personalized Medicine Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Personalized Medicine Production Overview
12.2 2016-2021 Personalized Medicine Production Market Share Analysis
12.3 2016-2021 Personalized Medicine Demand Overview
12.4 2016-2021 Personalized Medicine Supply Demand and Shortage
12.5 2016-2021 Personalized Medicine Import Export Consumption
12.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE PERSONALIZED MEDICINE KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Personalized Medicine Production Overview
14.2 2021-2025 Personalized Medicine Production Market Share Analysis
14.3 2021-2025 Personalized Medicine Demand Overview
14.4 2021-2025 Personalized Medicine Supply Demand and Shortage
14.5 2021-2025 Personalized Medicine Import Export Consumption
14.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
PART V PERSONALIZED MEDICINE MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN PERSONALIZED MEDICINE MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Personalized Medicine Marketing Channels Status
15.2 Personalized Medicine Marketing Channels Characteristic
15.3 Personalized Medicine Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN PERSONALIZED MEDICINE NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Personalized Medicine Market Analysis
17.2 Personalized Medicine Project SWOT Analysis
17.3 Personalized Medicine New Project Investment Feasibility Analysis
PART VI GLOBAL PERSONALIZED MEDICINE INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL PERSONALIZED MEDICINE PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Personalized Medicine Production Overview
18.2 2016-2021 Personalized Medicine Production Market Share Analysis
18.3 2016-2021 Personalized Medicine Demand Overview
18.4 2016-2021 Personalized Medicine Supply Demand and Shortage
18.5 2016-2021 Personalized Medicine Import Export Consumption
18.6 2016-2021 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL PERSONALIZED MEDICINE INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Personalized Medicine Production Overview
19.2 2021-2025 Personalized Medicine Production Market Share Analysis
19.3 2021-2025 Personalized Medicine Demand Overview
19.4 2021-2025 Personalized Medicine Supply Demand and Shortage
19.5 2021-2025 Personalized Medicine Import Export Consumption
19.6 2021-2025 Personalized Medicine Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL PERSONALIZED MEDICINE INDUSTRY RESEARCH CONCLUSIONS
